
    
      The decrease of quality of life in patients after heart transplantation in the long-term is
      determined by an increasing incidence of transplant vasculopathy and by
      immunosuppression-related side effects.Long-term administration of calcineurin inhibitors is
      associated with chronic nephrotoxicity.
    
  